Cytogen taps Schnittker as VP and CFO

TriMed Staff | | Health Imaging | Artificial Intelligence
Cytogen Corp. has tapped Christopher P. Schnittker as vice president and CFO. Before coming on board at Cytogen, Schnittker served as CFO at biopharmaceutical company  Genaera Corp. (formerly Magainin Pharmaceuticals Inc.) from June 2000 to August 2003. Prior to Genaera, Schnittker served at technology firm GSI Commerce Inc. as director of finance from August 1999 to May 2000 and controller from December 1997 to August 1999.

TriMed Staff

Related Content

New algorithm models radiologists' eye movements to interpret chest X-rays
Embracing the future: James Min left academia to push for a paradigm shift in preventive cardiology
Risk prediction algorithm slashes number of unnecessary thyroid nodule biopsies
GE HealthCare taps Enlitic for large-scale imaging data migration plans
Easy-to-use AI model effectively segments 80 structures on MRI
FDA clears AI software capable of reducing MRI acquisition times by up to 80%

Around the web

Cardiovascular Business
Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.

Radiology Business
The impact of Trump tariffs on iodine contrast media costs

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Cardiovascular Business
COVID-19 linked to accelerated plaque growth, long-term risk of heart attack or stroke

These risks appear to be present regardless of a person's age or health at the time of infection.